BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34828282)

  • 1. MUC14-Related ncRNA-mRNA Network in Breast Cancer.
    Wang S; Jin J; Chen J; Lou W
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828282
    [No Abstract]   [Full Text] [Related]  

  • 2. CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer.
    Wang K; Liao C; Zhong Q; Dong H; Zhang T; Jin R
    J Cell Biochem; 2019 Aug; 120(8):13509-13519. PubMed ID: 30927387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
    Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
    Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
    Liu Y; Wei G; Ma Q; Han Y
    Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.
    Li XY; Zhou LY; Luo H; Zhu Q; Zuo L; Liu GY; Feng C; Zhao JY; Zhang YY; Li X
    Aging (Albany NY); 2019 Aug; 11(15):5646-5665. PubMed ID: 31399552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of LncRNA-GACAT3 with MRI features of breast cancer and its molecular mechanism.
    Hu H; Wang Y; Zhang T; Zhang C; Liu Y; Li G; Zhou D; Lu S
    J BUON; 2019; 24(6):2377-2384. PubMed ID: 31983109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.
    Lin S; Zhao M; Lv Y; Mao G; Ding S; Peng F
    Aging (Albany NY); 2021 Apr; 13(10):13663-13679. PubMed ID: 33902008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
    Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
    Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis.
    Yin X; Wang P; Yang T; Li G; Teng X; Huang W; Yu H
    Aging (Albany NY); 2020 Dec; 13(2):2519-2538. PubMed ID: 33318294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
    Liu X; Yao W; Xiong H; Li Q; Li Y
    Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of competitive endogenous RNAs network in breast cancer.
    Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
    Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
    Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
    J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
    Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
    Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network.
    Zhu H; Lu J; Zhao H; Chen Z; Cui Q; Lin Z; Wang X; Wang J; Dong H; Wang S; Tan J
    Med Sci Monit; 2018 Nov; 24():8250-8263. PubMed ID: 30444862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
    Gao Z; Fu P; Yu Z; Zhen F; Gu Y
    Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.